-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Htg Molecular Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q1 2023.
- Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $137K, a 48.8% decline year-over-year.
- Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $643K, a 47.9% decline year-over-year.
- Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $774K, a 41.2% decline from 2021.
- Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.32M, a 16.9% decline from 2020.
- Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2020 was $1.58M, a 37% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)